IL6 and neoplasm: The secretion of IL-6 from MSCs increased the secretion of endothelin-1 (ET-1) in cancer cells, which induced the activation of protein kinase B α (AKT) and ERK in endothelial cells, thereby increasing their ability to recruit and sustain angiogenesis in the tumor [46].